
Oyster Point Pharmaceuticals
A clinical stage pharmaceutical company focused on the discovery development & commercialization .
Market cap
$300m
Enterprise value
$326m
Share price
$11.17 OYST
Authorizing premium user...
A clinical stage pharmaceutical company focused on the discovery development & commercialization .